Light therapy for depression

How light therapy works

Bright light delivered to the eyes in the morning shifts circadian rhythms earlier and suppresses melatonin. Both effects are believed to underlie the antidepressant action. The effect is mediated by intrinsically photosensitive retinal ganglion cells (ipRGCs) that respond to blue and broad-spectrum light and project to the suprachiasmatic nucleus, the brain region that governs the circadian clock.

The mechanism explains why timing matters more than total dose. Morning light advances the circadian phase, which is the desired direction in most depression. Evening bright light delays it, which can worsen sleep and mood.

Evidence in seasonal depression

Light therapy is a first-line treatment for seasonal affective disorder (SAD), with response rates of roughly 60 to 70 percent and effect sizes comparable to antidepressants. The American Psychiatric Association and Canadian guidelines (CANMAT) recommend it as a first-line option for fall-winter SAD.

Most patients notice improvement within one to two weeks. Continued use throughout the symptomatic season is the standard approach. Many patients combine light therapy with an SSRI in moderate to severe seasonal episodes.

Evidence in non-seasonal depression

The evidence base for non-seasonal depression has grown substantially in the past decade. The largest randomized trial (Lam et al., JAMA Psychiatry 2016) found that bright light therapy alone, fluoxetine alone, and the combination all outperformed placebo in non-seasonal depression, with the combination producing the highest response rates. A 2024 meta-analysis (Tao et al., JAMA Psychiatry) of 11 trials in non-seasonal depression confirmed a meaningful effect.

Light therapy is now reasonable to consider as an adjunct in non-seasonal depression, particularly when the patient has prominent fatigue, hypersomnia, sleep phase disruption, or the depression has not responded fully to standard treatment.

Dose and timing

The standard protocol:

• Intensity: 10,000 lux at the eyes (the lux measurement decreases with distance from the lamp).
• Duration: 30 minutes per session. Some protocols use 20 to 60 minutes.
• Timing: within the first hour of waking. Earlier is generally better. Late morning is acceptable; afternoon and evening are not first choice.
• Position: the lamp should be 16 to 24 inches from the face, angled slightly downward, with the patient seated. The light enters the eye through normal forward gaze. Looking directly into the lamp is not necessary or recommended.
• Activities: reading, eating, writing, working at a desk, or using a phone are all compatible with the session.

If 10,000 lux is uncomfortable, a 5,000 lux lamp used for 60 minutes provides a similar dose. Some patients tolerate this better in the first week.

What to look for in a lamp

Not all lamps marketed as light therapy products meet the dose used in the clinical trials. The features that matter:

• Lux output: 10,000 lux at the distance you will sit (most commonly 12 to 24 inches).
• UV filtering: the lamp should explicitly filter ultraviolet light. Look for "UV-free" in the product specifications.
• Light spectrum: broad-spectrum white light is the standard. Some lamps marketed as "blue light" use narrow-band blue and have evidence at much lower lux. Both work; broad-spectrum is the better-studied default.
• Size of the panel: larger panels deliver more even light and let the user move slightly without dropping below the therapeutic dose.
• Independent verification: the Center for Environmental Therapeutics maintains a list of lamps that meet research standards. Most well-known brands (Carex, Northern Light Technology, Verilux) include models that qualify.

Wake-up lights and dawn-simulator alarms are not the same as bright light therapy lamps. They have a smaller separate evidence base for some patients with seasonal symptoms but do not deliver the dose used in the standard protocols.

Side effects

Light therapy is well tolerated. The most common side effects in the first week are mild headache, eye strain, and nausea, all of which usually improve with continued use or with sitting slightly farther from the lamp. Insomnia or activation can occur with too-late dosing; moving the session earlier usually fixes it.

People with bipolar disorder need caution. Light therapy can shift bipolar depression toward mania or mixed states. Use under the guidance of a psychiatrist, often combined with a mood stabilizer, is the standard approach.

Eye safety: bright light therapy is safe for most eyes. People with retinal disease (macular degeneration, retinitis pigmentosa, diabetic retinopathy) or who take photosensitizing medications (some antipsychotics, isotretinoin, methoxsalen) should consult an eye doctor first.

How to combine light therapy with other treatments

Light therapy combines well with most depression treatments.

• Antidepressants: commonly combined. The Lam 2016 trial showed the highest response with fluoxetine plus light therapy.
• CBT: compatible. CBT for SAD specifically (Rohan et al.) has evidence as a non-medication option that prevents recurrence after treatment ends.
• Sleep regulation: bright light in the morning is itself part of sleep hygiene and is compatible with CBT for insomnia.
• Exercise: compatible. Outdoor morning exercise combines bright light with physical activity, both of which have evidence in depression.